Aberrant expression of GIP (Gastric Inhibitory Polypeptide) receptor in an adrenal cortical adenoma responsible for a case of food-dependent Cushing's syndrome;Expression aberrante du récepteur du GIP (Gastric Inhibitory Polypeptide) dans un adénome de la cortico-surrénale responsable d'un syndrome de Cushing dépendant de l'alimentation

Bulletin de l'Academie Nationale de Medecine

Volumn 182, Issue 9, 1998, Pages 1839-1849

  Luton, Jean Pierre ^a,b   Bertherat, Jérôme ^a,b   Kuhn, Jean Marc ^c   Bertagna, Xavier ^a,b  

^a Clin Malad Endocriniennes/M

^b université Paris Cité   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Cushing's syndrome; Endocrine gland neoplasms; Gastric inhibitory polypeptide; Receptors, gastrointestinal hormone

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; HORMONE RECEPTOR;

ADRENAL CORTEX TUMOR; ADULT; ARTICLE; CASE REPORT; CUSHING SYNDROME; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; POSTPRANDIAL STATE;

ADRENAL CORTEX NEOPLASMS; ADULT; CUSHING SYNDROME; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; POSTPRANDIAL PERIOD; RECEPTORS, GASTROINTESTINAL HORMONE;

EID: 0000335883     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. FOLLENIUS M., BRANDENBERGER G., HIETTER B., SIMÉNONI M., REINHARDT B. - Diurnal cortisol peaks and their relationships to meals. J. Clin. Endocrinol. Metab.,1982, 55, 757-61.
2. THORENS B. - Glucagon-like peptide-1 and control of insulin secretion. Diabete Metab.,1995, 21, 311-318.
3. LACROIX A., BOLTÉ E., TREMBLAY J. et al. - Gastric inhibitor polypeptide-dependent cortisol hypersecretion - A new cause of Cushing's syndrome N. Engl. J. Med.1992, 327, 974-980.
4. REZNIK Y., ALLALI-ZERAH V., CHAYVIALLE J.A. et al. - Food-dependent Cushing's syndrome mediated by abberant adrenal sensitivity to gastric inhibitory polypeptide. N. Engl. J. Med.,1992, 527, 981-986.
5. LACROIX A., TREMBLAY J., ROUSSEAU G., BOUVIER M., HAMET P. - Propranolol. Therapy for ectopic-adrenergic receptors in adrenal Cushing's syndrome. N. Engl J. Med.,1997, 337, 1429-1434.
6. MIRCESCU H., JILWAN J., HAMET P., LACROIX A. - Systematic clinical screening for abnormal hormone receptor in adrenal Cushing's syndrome. 80th Annual Meeting, American Endocrine Society, New Orleans, June1998, Abstract p. 80.
7. LACROIX A., TREMBLAY J., TOUYZ R. et al. - Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome and orthostatic hypotension. J. Clin. Endocrinol. Metab.,1997, 82, 2414-2422.
8. ARNALDI G., GASC J.-M., DE KEYZER Y., RAFFTN-SANSON M.-L., PERRAUDIN V., KUHN J.-M., RAUX-EURIN M.-C., LUTON J.-P., CLAUSER E., BERTAGNA X. - Variable expression of the VI vasopressin receptor modulates the phenotypic response of steroid secreting adrenocortical tumors. J. Clin. Endocrinol. Metab., 1998, 80,2029-2035.
9. PERRAUDIN V., DELARUE C., LEFEBVRE H., CONTESSE V., KUHN J.M., VAUDRY H. - Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of VI receptors. J. Clin. Endocrinol. Metab.,1993, 76, 1522-1528.
10. LACROIX A., N'DIAYE N., HAMET P., TREMBLAY J., BOUTIN J.-M., SAIRAM M.R. - LH-dependent Cushing's syndrome in a woman with bilateral macronodular adrenal hyperplasia : control of hypercortisolism with leuprolid. 80th Annual Meeting, American Endocrine Society, New Orleans, June1998, Abstract p. 80.
11. LUTON J.-P., BERTAGNA X. - Récepteurs membranaires et tumeurs endocrines : l'expression du récepteur V1 de la vasopressine module le phénotype pharmacologique des tumeurs de la corticosurrénale. Bull. Acad. Natle Med.,1998, 182, 299-310.
12. HAMET P., LAROCHELLE P., FRANKS D.J., CARTIER P., BOLTÉ E. - Cushing's syndrome with food-dependent hormonogenesis. Clin. Invest. Med.,1987, 10, 530-533.
13. DE HERDER W.W., HOFLAND L.J., USDIN T.B. et al. - Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. J. Clin. Endocrinol. Metab.,1996, 81, 3168-3172.
14. LANDIS C.A., MASTERS S.B., SPADA A., PACE A.M., BOURNE H.R., VALLAR L. - GTPase inhibiting mutations activate the alpha chain of G protein and stimulate adenylyl cyclase in human pituitary tumours. Nature,1989, 340, 692-696.
15. PARMA J., DUPREZ L., VANSANDE J. et al. - Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature,1993, 365, 649-651.
16. WEINSTEIN L., SHENKER A., GEJMAN P., MERINO M., FRIEDMAN E., SPIEGEL A. - Activating mutations of the stimulatory G protein mutations of the stimulatory G protein in the McCune-Albright syndrome. J. Engl. J. Med., 1991, 325,1688-1695.
17. SHENKER A., LAUE L., KOSUGI S., MERENDINO J.J., MINEGHISHI T., CUTLER G.B. - A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature,1993, 365, 652-654.
18. N'DIAYE N., TREMBLAY J., HAMET P., DE WERDER W.W., LACROIX A. - Adrenocorticol overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome. J. Clin. Endocrinol. Metab., 1998, 83, 8,2781-5.